BMA
ABT icon

Brooks Moore & Associates’s Abbott ABT Stock Holding History

Brooks Moore & Associates’s Portfolio ABT Stock Details ABT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.14M Buy
40,305
+993
+3% +$112K 2.07% 16
2025
Q4 		$4.93M Buy
39,312
+585
+2% +$74.5K 2.42% 11
2025
Q3 		$5.19M Sell
38,727
-332
-0.8% -$43.6K 2.63% 8
2025
Q2 		$4.93M Sell
39,059
-143
-0.4% -$18.9K 2.66% 8
2025
Q1 		$5.2M Sell
39,202
-505
-1% -$64.3K 2.93% 9
2024
Q4 		$4.49M Sell
39,707
-120
-0.3% -$13.9K 2.66% 13
2024
Q3 		$4.54M Hold
39,827
– – 2.68% 11
2024
Q2 		$4.14M Buy
39,827
+1,035
+3% +$110K 2.66% 12
2024
Q1 		$4.41M Sell
38,792
-613
-2% -$70.3K 2.83% 10
2023
Q4 		$4.34M Sell
39,405
-240
-0.6% -$24K 2.98% 10
2023
Q3 		$3.84M Sell
39,645
-200
-0.5% -$21K 2.9% 9
2023
Q2 		$4.34M Sell
39,845
-900
-2% -$95.9K 3.06% 8
2023
Q1 		$4.13M Sell
40,745
-4,793
-11% -$506K 2.96% 10
2022
Q4 		$5M Buy
45,538
+300
+0.7% +$31.1K 3.65% 5
2022
Q3 		$4.38M Sell
45,238
-300
-0.7% -$32K 3.54% 5
2022
Q2 		$4.95M Sell
45,538
-169
-0.4% -$19.2K 3.57% 4
2022
Q1 		$5.41M Sell
45,707
-340
-0.7% -$42.1K 3.32% 3
2021
Q4 		$6.48M Sell
46,047
-375
-0.8% -$48K 3.8% 2
2021
Q3 		$5.48M Sell
46,422
-200
-0.4% -$24.6K 3.59% 2
2021
Q2 		$5.41M Buy
46,622
+300
+0.6% +$35K 3.45% 2
2021
Q1 		$5.55M Buy
46,322
+65
+0.1% +$7.7K 3.76% 2
2020
Q4 		$5.07M Sell
46,257
-540
-1% -$58.7K 3.92% 2
2020
Q3 		$5.09M Sell
46,797
-825
-2% -$83.7K 4.39% 2
2020
Q2 		$4.35M Sell
47,622
-6,625
-12% -$599K 4.08% 2
2020
Q1 		$4.28M Sell
54,247
-1,598
-3% -$133K 4.55% 2
2019
Q4 		$4.85M Sell
55,845
-475
-0.8% -$39.8K 3.85% 2
2019
Q3 		$4.71M Sell
56,320
-1,302
-2% -$111K 3.98% 2
2019
Q2 		$4.85M Sell
57,622
-6,250
-10% -$492K 4.16% 1
2019
Q1 		$5.11M Sell
63,872
-9,240
-13% -$687K 4.66% 1
2018
Q4 		$5.29M Buy
+73,112
New +$5.14M 5.32% 1

Other funds holding ABT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Brooks Moore & Associates's ABT Position: Q1 2026 in Review

Brooks Moore & Associates increased its Abbott (ABT) stake by 2.5% in Q1 2026, buying an estimated $112K and bringing the position to 40,305 shares worth $4.14M. The position accounts for 2.07% of the portfolio, ranked #16.

Brooks Moore & Associates first reported a position in ABT in Q4 2018 and has held it in 30 quarters since. The position peaked at $6.48M in Q4 2021. 3,087 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • Brooks Moore & Associates held 40,305 shares of Abbott worth $4.14M as of Q1 2026.
  • Brooks Moore & Associates bought 993 Abbott shares in Q1 2026, an estimated $112K.
  • Abbott made up 2.07% of Brooks Moore & Associates's portfolio in Q1 2026, its #16 holding.
  • Brooks Moore & Associates first reported a position in Abbott in Q4 2018 and has held it in 30 quarters since.
  • Brooks Moore & Associates's Abbott position peaked at $6.48M in Q4 2021.
  • 3,087 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Brooks Moore & Associates's 13F filing for Q1 2026, filed 15 May 2026.